Oxidative status, inflammation, and postoperative atrial fibrillation with metoprolol vs carvedilol or carvedilol plus n-acetyl cysteine treatment

Clinical Cardiology

Volumn 37, Issue 5, 2014, Pages 300-306

  Ozaydin, Mehmet ^a   Peker, Oktay ^a   Erdogan, Dogan ^a   Akcay, Selahaddin ^a   Yucel, Habil ^a   Icli, Atilla ^a   Ceyhan, Betul M ^a   Sutcu, Recep ^a   Uysal, Bayram A ^a   Varol, Ercan ^a   Dogan, Abdullah ^a   Okutan, Huseyin ^a  

^a SULEYMAN DEMIREL UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARVEDILOL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; METOPROLOL; SPIRONOLACTONE; ANTIHYPERTENSIVE AGENT; CARBAZOLE DERIVATIVE; PROPANOLAMINE DERIVATIVE; SCAVENGER;

ADULT; ANGINA PECTORIS; ANTIOXIDANT ACTIVITY; ARTICLE; AUTOANALYZER; BLOOD PRESSURE; CARDIOPULMONARY BYPASS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DIABETES MELLITUS; DOUBLE BLIND PROCEDURE; ELECTROCARDIOGRAPHY MONITORING; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART RATE; HUMAN; HYPERTENSION; INFLAMMATION; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SPECTROPHOTOMETRY; TOTAL ANTIOXIDANT CAPACITY; TREATMENT OUTCOME; AGED; ATRIAL FIBRILLATION; COMPARATIVE STUDY; DRUG COMBINATION; DRUG EFFECTS; HEART SURGERY; MIDDLE AGED; PATHOPHYSIOLOGY;

ACETYLCYSTEINE; AGED; ANTIHYPERTENSIVE AGENTS; ATRIAL FIBRILLATION; CARBAZOLES; CARDIAC SURGICAL PROCEDURES; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; FREE RADICAL SCAVENGERS; HUMANS; INFLAMMATION; LEUKOCYTE COUNT; MALE; METOPROLOL; MIDDLE AGED; OXIDATIVE STRESS; POSTOPERATIVE PERIOD; PROPANOLAMINES; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84900824415     PISSN: 01609289     EISSN: 19328737     Source Type: Journal    
DOI: 10.1002/clc.22249     Document Type: Article

References (37)

1. Elahi MM, Flatman S, Matata BM,. Tracing the origins of postoperative atrial fibrillation: the concept of oxidative stress-mediated myocardial injury phenomenon. Eur J Cardiovasc Prev Rehabil. 2008; 15: 735-741.
2. Baker WL, Anglade MW, Baker EL, et al. Use of N-acetyl cysteine to reduce post-cardiothoracic surgery complications: a metaanalysis. Eur J Cardiothorac Surg. 2009; 35: 521-527.
3. Kumagai K, Nakashima H, Saku K,. The HMG-CoA reductase inhibitor atorvastatin prevents atrial fibrillation by inhibiting inflammation in a canine sterile pericarditis model. Cardiovasc Res. 2004; 62: 105-111.
4. Carnes CA, Chung MK, Nakayama T, et al. Ascorbate attenuates atrial pacing-induced peroxynitrite formation and electrical remodeling and decreases the incidence of postoperative atrial fibrillation. Circ Res. 2001; 89: e32-e38.
5. Koroglu S, Tuncer C, Acar G, et al. Relation of inflammatory and oxidative markers to the occurrence and recurrence of persistent atrial fibrillation. Turk Kardiyol Dern Ars. 2012; 40: 499-504.
6. Arumanayagam M, Chan S, Tong S, et al. Antioxidant properties of carvedilol and metoprolol in heart failure: a double-blind randomized controlled trial. J Cardiovasc Pharmacol. 2001; 37: 48-54.
7. El-Sheriff N, Turitto G,. Electrophysiologic effects of carvedilol: is carvedilol an antiarrhythmic agent? Pacing Clin Electrophysiol. 2005; 28: 985-990.
8. Sucu N, Cinel I, Unlu A, et al. N-Acetylcysteine for preventing pump induced oxidoinflammatory response during cardiopulmonary bypass. Surg Today. 2004; 34: 237-242.
9. Koramaz I, Pulathan Z, Usta S, et al. Cardioprotective effect of cold blood cardioplegia enriched with N-acetylcysteine during coronary artery bypass grafting. Ann Thorac Surg. 2006; 81: 613-618.
10. Vento AE, Nemlander A, Aittomaki J, et al. N-Acetylcysteine as an additive to crystalloid cardioplegia increased oxidative stress capacity in CABG patients. Scand Cardiovasc J. 2003; 37: 349-355.
11. Tossios P, Bloch W, Huebner A, et al. N-Acetylcysteine prevents reactive oxygen species-mediated myocardial stress in patients undergoing cardiac surgery: results of a randomized, double-blind, placebo-controlled clinical trial. J Thorac Cardiovasc Surg. 2003; 126: 1513-1520.
12. Forman MB, Puett DW, Cates CU, et al. Glutathione redox pathway and reperfusion injury. Effect of N-acetylcysteine on infarct size and ventricular function. Circulation. 1988; 78: 202-213.
13. Orhan G, Yapici N, Yuksel M, et al. Effects of N-acetylcysteine on myocardial ischemia-reperfusion injury in bypass surgery. Heart Vessels. 2006; 21: 42-47.
14. Kurum T, Tatli E, Yuksel M,. Effects of carvedilol on plasma levels of pro-inflammatory cytokines in patients with ischemic and nonischemic dilated cardiomyopathy. Tex Heart Inst J. 2007; 34: 52-59.
15. Tatli E, Kurum T,. A controlled study of the effects of carvedilol on clinical events, left ventricular function and proinflammatory cytokines levels in patients with dilated cardiomyopathy. Can J Cardiol. 2005; 21: 344-348.
16. Alfieri AB, Briceno L, Fragasso G, et al. Differential long-term effects of carvedilol on proinflammatory and antiinflammatory cytokines, asymmetric dimethylarginine, and left ventricular function in patients with heart failure. J Cardiovasc Pharmacol. 2008; 52: 49-54.
17. Gu WJ, Wu ZJ, Wang PF, et al. N-Acetyl cysteine supplementation for the prevention of atrial fibrillation after cardiac surgery: a meta-analysis of eight randomized controlled trials. BMC Cardiovasc Disord. 2012; 12: 10.
18. Wang G, Bainbridge D, Martin J, et al. N-acetyl cysteine in cardiac surgery: do the benefits outweigh the risks? A meta-analytic reappraisal. J Cardiothorac Vasc Anesth. 2011; 25: 268-275.
19. Ozaydin M, Peker O, Erdogan D, et al. N-acetyl cysteine for the prevention of postoperative atrial fibrillation: a prospective, randomized, placebo-controlled pilot study. Eur Heart J. 2008; 29: 625-631.
20. Haghjoo M, Saravi M, Hashemi MJ, et al. Optimal beta-blocker for prevention of atrial fibrillation after on-pump coronary artery bypass graft surgery: carvedilol versus metoprolol. Heart Rhythm. 2007; 4: 1170-1174.
21. Acikel S, Bozbas H, Gultekin B, et al. Comparison of the efficacy of metoprolol and carvedilol for preventing atrial fibrillation after coronary bypass surgery. Int J Cardiol. 2008; 126: 108-113.
22. Merritt JC, Niebauer M, Tarakji K, et al. Comparison of effectiveness of carvedilol versus metoprolol or atenolol for atrial fibrillation appearing after coronary artery bypass grafting or cardiac valve operation. Am J Cardiol. 2003; 92: 735-736.
23. Ozaydin M, Icli A, Yucel H, et al. Metoprolol versus carvedilol or carvedilol plus N-acetyl cysteine on postoperative atrial fibrillation: a randomized, double-blind, placebo-controlled study. Eur Heart J. 2013; 34: 597-604.
24. Erel O., A novel automated direct measurement method for total antioxidant capacity using a new generation, more stable ABTS radical cation. Clin Biochem. 2004; 37: 277-285.
25. Erel O., A new automated colorimetric method for measuring total oxidant status. Clin Biochem. 2005; 38: 1103-1111.
26. Korantzopoulos P, Kolettis TM, Galaris D, et al. The role of oxidative stress in the pathogenesis and perpetuation of atrial fibrillation. Int J Cardiol. 2007; 115: 135-143.
27. Patti G, Chello M, Candura D, et al. Randomized trial of atorvastatin for reduction of postoperative atrial fibrillation in patients undergoing cardiac surgery: results of the ARMYDA-3 (Atorvastatin for Reduction of MYocardial Dysrhythmia After cardiac surgery) study. Circulation. 2006; 114: 1455-1461.
28. Kim YH, Lim DS, Lee JH, et al. Gene expression profiling of oxidative stress on atrial fibrillation in humans. Exp Mol Med. 2003; 35: 336-349.
29. Mihm MJ, Yu F, Carnes CA, et al. Impaired myofibrillar energetics and oxidative injury during human atrial fibrillation. Circulation. 2001; 104: 174-180.
30. Neuman RB, Bloom HL, Shukrullah I, et al. Oxidative stress markers are associated with persistent atrial fibrillation. Clin Chem. 2007; 53: 1652-1657.
31. Li J, Solus J, Chen Q, et al. Role of inflammation and oxidative stress in atrial fibrillation. Heart Rhythm. 2010; 7: 438-444.
32. Farah R, Shurtz-Swirski R, Bolotin Y, et al. Oxidative stress and inflammation due to peripheral polymorphonuclear leukocytes after coronary angiography vs percutaneous coronary intervention. Minerva Cardioangiol. 2008; 56: 189-195.
33. Lamm G, Auer J, Weber T, et al. Postoperative white blood cell count predicts atrial fibrillation after cardiac surgery. J Cardiothorac Vasc Anesth. 2006; 20: 51-56.
34. Sabol F, Jakubova M, Mitro P, et al. Is there a relationship between inflammatory markers, oxidative stress and postoperative atrial fibrillation [in Slovak]? Vnitr Lek. 2012; 58: 730-734.
35. Abdelhadi RH, Gurm HS, Van Wagoner DR, et al. Relation of an exaggerated rise in white blood cells after coronary bypass or cardiac valve surgery to development of atrial fibrillation postoperatively. Am J Cardiol. 2004; 93: 1176-1178.
36. Rodrigo R, Korantzopoulos P, Cereceda M, et al. A randomized controlled trial to prevent post-operative atrial fibrillation by antioxidant reinforcement. J Am Coll Cardiol. 2013; 62: 1457-1465.
37. El-Hamamsy I, Stevens LM, Carrier M, et al. Effect of intravenous N-acetylcysteine on outcomes after coronary artery bypass surgery: a randomized, double-blind, placebo-controlled clinical trial. J Thorac Cardiovasc Surg. 2007; 133: 7-12.